Skip to main content

Mayo Clinic Comprehensive Cancer Center

Mayo Clinic Comprehensive Cancer Center was one of the first cancer centers to receive the NCI designation in 1973. Today, it is the only NCI-Designated Comprehensive Cancer Center with three locations in Arizona, Florida, and Minnesota.

For more than 50 years, Mayo Clinic has helped transform the nation's cancer research efforts by focusing on a team approach to find new and better ways to prevent, intercept, diagnose and treat cancer. Every year, more than 130,000 people with cancer come to Mayo Clinic from all walks of life and from around the world to receive precision diagnoses and treatments tailored to their exact needs and cancer types.

Read more about the Mayo Clinic Comprehensive Cancer Center. 

Mayo Clinic

Comp
Cheryl L. Willman, MD
Director
200 First Street, S.W
Rochester, MN 55905
(507) 266-4997

Senior Leaders

Senior Leader Title
Bruce F Horazdovsky, PhD Enterprise Deputy Director, Research Education and Training
Cheryl L Willman, MD Director and Principal Investigator; Enterprise Executive Director, Mayo Clinic Cancer Programs and Mayo Clinic Comprehensive Cancer Center
Cui Tao, PhD Enterprise Co-Deputy Director, Data Science/Artificial Intelligence
Daniel D Billadeau, PhD Enterprise Deputy Director, Basic Research
Daniel D Billadeau, PhD Enterprise Deputy Director, Shared Resources
Eric W Klee, PhD Enterprise Co-Deputy Director, Data Science/Artificial Intelligence
Felicity T Enders, PhD Enterprise Deputy Director, Diversity, Equity, and Inclusion
Folakemi Odedina, PhD Enterprise Deputy Director, Community Outreach and Engagement
Grzegorz S Nowakowski, MD Enterprise Deputy Director, Clinical Research
James R Cerhan, MD, PhD Enterprise Deputy Director, Population Sciences
Jolene M Summer Bolster, MA Enterprise Deputy Director for Administration
Matthew P Goetz, MD Enterprise Deputy Director, Translational Research
Richard J Bold, MD, MBA Site Deputy Director, Arizona
Roxana S Dronca, MD Site Deputy Director, Florida
Stephen M Ansell, MD, PhD Site Deputy Director, Rochester/Midwest; Enterprise Deputy Director
TBN Enterprise Associate Director for Administration

Research Programs

Research Program Program Leaders
Advanced Clinical Trials and Translational Sciences Tanios Bekaii-Saab, MD; Leif Bergsagel, MD; Amy Degnim, MD; Jann Sarkaria, MD
Cancer Cell Genomics, Signaling and Metastasis Panos Anastasiadis, PhD; Zhenkun Lou, PhD; Mark McNiven, PhD
Cancer Immunology and Immunotherapeutics Saad Kenderian, MB, CHB; Keith Knutson, PhD; Virginia Shaprio, PhD
Cancer Prevention, Control, and Survivorship Janice Krieger, PhD; Kathryn Ruddy, MD; Lila Rutten, PhD
Cancer Risk Assessment, Early Detection and Interception Ajit Goenka, MD; Shaji Kumar, MD; Mark Sherman, PhD
Novel Therapeutics and Therapeutic Modalitities Mitesh Borad, MD; Scott Kaufmann, MD,PhD; Virginia Shapiro, PhD

Shared Resources

Category Resource Directors
Cat 1: Laboratory Science Genome Analysis Stephen Murphy, PhD
Cat 1: Laboratory Science Immune Monitoring JC Villaboas Bisneto, MD
Cat 1: Laboratory Science Microscopy and Cell Analysis Jeffrey Salisbury, PhD
Cat 1: Laboratory Science Pharmacology Joel Reid, PhD
Cat 1: Laboratory Science Proteomics Akhilesh Pandey, MD, PhD
Cat 1: Laboratory Science Transgenic and Knockout Darren Baker, PhD
Cat 3: Epidemiology, Cancer Control Survey Research Kathleen Yost, PhD
Cat 4: Clinical Research Biospecimens Accessioning and Processing Mine Cicek, PhD
Cat 4: Clinical Research Pathology Research Thomas Flotte, MD
Cat 6: Biostatistics Biostatistics Karla Ballman, PhD
Cat 7: Informatics Bioinformatics Karla Ballman, PhD
Last Updated
April 24, 2025